Category:
Prophylactic Biological Products
CAS NO:
1038915-60-4
Standard:
In-house Standards,

Niraparib (trade name Zejula) is developed by Tesaro company poly adenosine diphosphate ribose polymerase (PARP) polybosphateadenosineribosepolymerase, inhibitor, can inhibit DNA repair.
Indication: Ovarian/Fallopian/tupe/primary/peritoneal cancer
All the products under the patent are only for R&D use.
Patent from Tesard, expiry date(The U.S):Jan. 8,2028